American Cannabis News

Cannabis Companies Ended 2025 with Weakening Financial Positions – New Cannabis Ventures

Published

2 months ago

March 21, 2026

admin

Cannabis Companies Ended 2025 with Weakening Financial Positions – New Cannabis Ventures

It Public Hemp Company Revenue and Earnings Trackingrun by New Cannabis Ventures, ranks the leading cannabis companies. This update is our first since mid-February when we previewed Q4 reports.

Tracking rules

This data-driven, fact-based search engine will be continually updated based on new financial filings so readers can stay up-to-date. Companies must file with the SEC or SEDAR and be current to be considered for inclusion. When we launched this resource in May 2019, companies with more than $2.5 million in quarterly revenue qualified. As the industry has grown and as more companies have gone public, we have raised the minimum several times, including $5 million in October 2019, $7.5 million in June 2020, up to $10 million in November 2020, $12.5 million in August 2021, $12.5 million in August 2021, and $202 in September 2021. million dollars. hemp industry, we raised the minimum again in May 2024. The senior list has a minimum of US$50 million (C$68.4 million) and the junior list now has a minimum of US$25 million (C$34.2 million).

Note on adjusted operating income

In May 2019, we added an additional measure, Adjusted Operating Income, which we detailed in our newsletter. The calculation takes reported operating income and adjusts it for any changes in the fair value of biological assets required under IFRS accounting. We believe this adjustment improves comparability between companies under IFRS and GAAP accounting. We note that operating income can often include one-time items such as stock compensation, inventory write-offs or public listing costs, and we encourage readers to understand how these non-cash items may impact quarterly financials. Many companies have moved from IFRS to US GAAP accounting, which has reduced our need to make adjustments. Please note that our rating only includes actual reported income and non pro forma income. We also note that companies with non-hemp operations must provide segment-level financial statements detailing not only revenue but also operating profit in order for their operating profit to be included in the tracking. Currently, Jazz Pharma (NASDAQ: JAZZ ) and Tilray (TSX: TLRY ) (NASDAQ: TLRY ) do not provide this information.

Tracker inclusion updates

At the time of our last update on February 17th, 19 companies were eligible for inclusion on the senior lists, including 15 in USD and 4 in Canadian currency, while there were 11 companies on the junior lists. Now, 14 companies denominated in US dollars and 4 denominated in Canadian dollars qualify for the senior lists, for a total of 18 now. The junior list includes 10 companies denominated in US dollars and 2 in Canadian dollars. Tracking public cannabis company revenue and earnings on a combined basis now includes 30 companies. US senior listing could lose Cannabist (OTC: CBSTF ) if it fails to report its Q4 financials.

Companies that have reported since mid-February are included

Most of these companies are in December year-end and the year-end reports are almost completely done. This section introduces important changes. The next big reporting season is in mid-May, although a few companies will report before then.

Senior and Junior – US Dollar Report

Q4 reports began in late February and are still ongoing, with Glass House (OTC: GLASF ) reporting Tuesday afternoon. 7 MSOs reported more than $100 million in Q4 revenue with minimal operating income or losses. Growth has been very slow for the top 5 countries, with annual growth ranging from -8% to 6%.

None of the Big 5 MSOs have yet scheduled calls for their Q1 financials in May, although GTI has changed its policy and will not be hosting any for now. Here’s the current outlook for all of them in 2026, according to Coifin.

Curaleaf (OTC: CURLF ) (TSX: CURA ) – revenue is expected to increase 5% to $1.33 billion on adjusted EBITDA of $262.6 million, up 3%.
Green Thumb Industries (OTC: GTBIF ) (CSE: GTII ) – revenue is expected to increase 3% to $1.21 billion with adjusted EBITDA up 3% to $332.5 million.
Trulieve (OTC: TCNNF ) (CSE: TRUL ) – Revenue is expected to decline 1% to $1.17 billion and adjusted EBITDA is expected to decline 6% to $400.4 million.
Verano Holdings (OTC: VRNO ) (NEO: VRNO ) – revenue is expected to rise 1% to $829.3 million, with adjusted EBITDA expected to decline 1% to $225.9 million.
Cresco Labs (OTC: CRLBF ) (CSE: CL ) – Revenue is expected to decline 5% to $622.2 million and adjusted EBITDA is expected to decline 8% to $145.5 million.

Senior and Junior – Canadian Dollar Report

High Tide (NASDAQ: HITI ) (TSXV: HITI ) recently reported its 4th quarter, and since then, the stock has taken a nosedive.

Auxly (TSX: XLY ) (OTC: CBWTF ) has yet to report Q4.

The Public Cannabis Company Earnings Tracker by New Cannabis Ventures is not a recommendation of any company, and you should not use it as investment advice. A tilde next to a date means an approximate date. All calculations are derived from SEC or SEDAR filings. Any questions or licensing inquiries please contact us.

Did you miss something? Catch them all! Cannabis Revenue Tracking Updates.

Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El

In this article.

cl:, Cresco Labs, CRLBF:, treatment, Curaleaf:, curly, Green Thumb Industries, gtbif:, gti:, high tide, heat, tcnnf:, Tilray brands, TLRY:, WRONG:, to truly believe, summer, WITH:, MOGET:

Related Topics:Cannabis Companies Ended Financial Positions Ventures Weakening

Up Next

Marijuana Retail Report

Don't Miss

Canadian Cannabis Sales Began 2026 with Growth – New Cannabis Ventures

280E

Cannabis Stock Q1 Financial Reports Were Not the Story – New Cannabis Ventures

Published

1 week ago

May 15, 2026

admin

Cannabis Stock Q1 Financial Reports Were Not the Story – New Cannabis Ventures

You are reading this week’s edition of New Cannabis Ventures, a weekly magazine we have published since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve, as well as links to the most important news of the week. We no longer email them like we used to, but post this and all newsletters on our website here.

friends,

Many more cannabis companies reported Q1 financials this week. While NCV did not run any of those press releases, all data has been updated in the New Cannabis Ventures Public Cannabis Company Revenue & Income Tracker. The largest companies reporting in US dollars all reported, and the eleven companies that reported for the Q1 ended in March (excluding Tilray Brands, which is due to report its Q4 later this month) saw an average year-over-year revenue increase of 31% in their cannabis businesses.

Excluding Vireo Growth, that average comes to -0.7%, which is lower, especially after accounting for inflation, and a sign of continued challenges for the hemp industry. Speaking of Vireo, I’ve pointed out how investors didn’t care, and they still don’t. An average of just 375,000 shares traded per day over the past month, and the stock, which closed at $0.415, continues to trade off the level of its late 2024 capital raise and the price at which the company issued shares to make multiple acquisitions.

April was a big month for hemp stocks, but prices fell in May. The NCV Global Cannabis Stock Index rose 8.8% to 5.70 in April, but fell 2.8% to 5.54 in May. The year-to-year change of this index, which now covers 23 stocks, was -15.9%. Since its peak in early 2021, the GCSI is down 94%. Many are excited about the medical cannabis realignment that took place in April, although it remains unclear whether cannabis will be completely overhauled. The Department of Justice will hold hearings in late June to discuss adult-use cannabis, and it could be. If so, 280E tax would be removed, and this would be very good. I’ve written a lot about this since late 2022 when I highlighted it The potential end of 280E as a major catalyst.

The investor base in cannabis stocks has shrunk due to capital losses and fewer people interested in the sector. Institutions were more interested in high prices and maybe they would enter the field. 280E remains a big story, and not only is it being delayed by the limited realignment that’s already been completed, it’s unclear how unpaid taxes from the last few years will be treated.

NCV has stopped publishing most cannabis news, although we continue to update the financial calendar as well as the earnings rankings. After more than 10 years with NCV and more than a dozen years with 420 Investor, I am in the process of moving on. This is probably the last weekly newsletter. I’ve appreciated sharing the news and my views here, and I want to wish everyone the best. Hopefully, 280E taxation will be fully completed and the bear market that began in early 2021 for the hemp sector will be over.

Sincerely,

Alan:

Contact us acquire NCV assets or a website domain

New Cannabis Ventures publishes curated articles as well as exclusive news. Here is what we published last week.

Exclusives

Michigan cannabis sales are down again

View: Public Hemp Company Revenue and Earnings Trackingwhich ranks the highest-earning hemp stocks.

Stay on top of the most important communications from public companies by watching what’s coming cannabis investor calendar.

aawh

Michigan Cannabis Sales Fell Yet Again – New Cannabis Ventures

Published

2 weeks ago

May 13, 2026

admin

Michigan Cannabis Sales Fell Yet Again – New Cannabis Ventures

Michigan April hemp sale decreased compared to a year ago, as they increased sequentially by 1.2%. At $258.6 million, sales decreased by 4.3 percent compared to last year.

Michigan’s cannabis regulatory agency breaks down sales by medical and adult use, with medical sales down 24.1% year-over-year to $0.4 million, down 5.6% sequentially, and adult-use sales down 4.3% year-over-year to $255.5 million, despite a one-day increase of 1.2% in March.

The state breaks down sales by category and provides pricing details by category for both medical and adult;

280E

Cannabis Stocks Are Going Nowhere Quickly – New Cannabis Ventures

Published

3 weeks ago

May 7, 2026

admin

Cannabis Stocks Are Going Nowhere Quickly – New Cannabis Ventures

friends,

The New Cannabis Ventures Global Cannabis Stock Index edged up slightly in May, rising 1.1% to 5.76. Compared to the previous year, it decreased by 12.6%. The index, recalculated as of the end of the first quarter, is up 9.9% so far in the second quarter, lagging the S&P 500’s 12.8% gain. Here are the earnings of the 23 names currently in the index (SMG was dropped in late April after the sale of Hawthorne Gardening):

MSOs are very much higher as the rally approaches the discussion of the big transformation announcements on 4/22 and beyond. There are currently six MSOs and two of them have been promoted. The rest rose, and the average of the six was 38.1%. The AdvisorShares Pure US Cannabis ETF ( MSOS ) has rallied 48.5% since the end of March and is now up 11.7% year-to-date in 2026. Both GCSI names have fallen sharply, and the index has a total of seven double-digit gains in Q2, with six MSOs and Canopy holding investments. 14 of the 23 names returned less than GCSI.

As readers are probably aware, the US reclassified medical cannabis from Schedule I to Schedule III on 4/23, and that will go away. 280E tax for some of the businesses of cannabis companies. The Department of Justice will hold a hearing in late June to determine possible rezoning for adult use. If it passes, all 280E taxation will end, which is a good thing for cannabis companies and their investors, as well as the subsidiaries that serve them. It is not yet known what the outcome will be, and it is not yet known how past 280E taxes that have not been paid but are carried as liabilities (and not debt) will be handled. Also, there is no conclusion yet on SECURITY banking or the possibility of a raise.

NCV has stopped publishing news, although we continue to update the financial calendar as well as the earnings rankings. After more than 10 years with NCV and more than a dozen years with 420 Investor, I am in the process of moving on. I’ve appreciated sharing the news and my views here, and I want to wish everyone the best. Hopefully, the 280E taxation will end and the bear market that started in early 2021 for the hemp sector will come to an end.

Sincerely,

Alan:

This week’s newsletter is sponsored by the Paul E. Saperstein Co.

Massachusetts hemp production equipment for sale

On May 12, Middlesex Integrative Medicine, Inc.’s equipment is being auctioned online in Leominster, Massachusetts at 10:00 a.m. ET. All applications must be submitted online. Learn more Of the secured party’s sale of all assets of this cultivation equipment.

Interested parties may contact Paul Cotto at 617-227-6553 or email pcotto@pesco.com:.

New Cannabis Ventures publishes curated articles as well as exclusive news. Here is what we have published in the last 2 weeks.

Exclusives

Sales of Canadian hemp continued in February

View: Public Hemp Company Revenue and Earnings Trackingwhich ranks the highest-earning hemp stocks.

Stay on top of the most important communications from public companies by watching what’s coming cannabis investor calendar.